Sign In
Buy VNDA
Vanda Pharmaceuticals Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be negative at -10.63. In total, the insiders bought 4.18M and sold 783.36K VNDA shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
-10.63 |
| ● Buy | 4.18M shares |
| ● Sell | 783.36K shares |
|
77% Buy Activity
Negligible or No Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
May 18, 2026 Sell |
Mitchell Stephen Ray Director |
25 836 Value: $0 |
||
|
Apr 22, 2026 Buy |
Duncan Charles Cliff Director |
57 101 Value: $390.0K |
||
|
Apr 22, 2026 Buy |
Duncan Charles Cliff Insider |
0 Value: $0 |
||
|
Apr 01, 2026 Buy |
Howell Scott Laverne Vp And Chief People Officer |
25 000 Value: $283.0K |
||
|
Apr 01, 2026 Buy |
Howell Scott Laverne Vp And Chief People Officer |
28 600 Value: $580.0K |
||
|
Apr 01, 2026 Buy |
Howell Scott Laverne Vp And Chief People Officer |
61 200 Value: $695.2K |
||
|
Apr 01, 2026 Buy |
Howell Scott Laverne Vp And Chief People Officer |
77 500 Value: $546.4K |
||
|
Apr 01, 2026 Buy |
Howell Scott Laverne Vp And Chief People Officer |
0 Value: $0 |
||
|
Apr 01, 2026 Buy |
Howell Scott Laverne Vp And Chief People Officer |
0 Value: $0 |
||
|
Apr 01, 2026 Buy |
Howell Scott Laverne Vp And Chief People Officer |
0 Value: $0 |
||
|
Apr 01, 2026 Buy |
Polymeropoulos Christos Vasilios Mihael Senior Vp, Medical Director |
0 Value: $0 |
||
|
Apr 01, 2026 Buy |
Polymeropoulos Christos Vasilios Mihael Senior Vp, Medical Director |
0 Value: $0 |
||
|
Apr 01, 2026 Buy |
Polymeropoulos Christos Vasilios Mihael Senior Vp, Medical Director |
0 Value: $0 |
||
|
Apr 01, 2026 Buy |
Polymeropoulos Christos Vasilios Mihael Senior Vp, Medical Director |
0 Value: $0 |
||
|
Apr 01, 2026 Buy |
Polymeropoulos Christos Vasilios Mihael Senior Vp, Medical Director |
0 Value: $0 |
||
|
Apr 01, 2026 Buy |
Polymeropoulos Christos Vasilios Mihael Senior Vp, Medical Director |
61 200 Value: $431.5K |
||
|
Apr 01, 2026 Buy |
Howell Scott Laverne Vp And Chief People Officer |
0 Value: $0 |
||
|
Apr 01, 2026 Buy |
Howell Scott Laverne Vp And Chief People Officer |
0 Value: $0 |
||
|
Apr 01, 2026 Buy |
Howell Scott Laverne Vp And Chief People Officer |
0 Value: $0 |
||
|
Mar 02, 2026 Sell |
Williams Timothy SVP & General Counsel |
42 434 Value: $350.8K |
||
|
Mar 02, 2026 Sell |
Moran Kevin Patrick SVP, CFO & Treasurer |
42 442 Value: $350.8K |
||
|
Mar 02, 2026 Sell |
Wijkstrom Joakim SVP, Chief Marketing Officer |
30 800 Value: $254.6K |
||
|
Mar 02, 2026 Sell |
Polymeropoulos Mihael Hristos President And CEO |
156 235 Value: $1.28M |
||
|
Mar 02, 2026 Sell |
Birznieks Gunther SVP, Business Development |
42 431 Value: $350.7K |
||
|
Feb 23, 2026 Sell |
Honore Tage Director |
30 000 Value: $240.9K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
